Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Diamyd’s diabetes vaccine found effective in Phase IIb study
The 30 month results comprise the final timepoint for the now-completed Diamyd study. Positive results have previously been reported after 15 and 21 months. The Phase IIb study
The 30 month results comprise the final timepoint for the now-completed Diamyd study. Positive results have previously been reported after 15 and 21 months. The Phase IIb study
The clinical studies evaluated the effect of the filter on units of red cell concentrate collected from human volunteers, to ensure that the use of the filter had
The therapeutic areas included in these awards are oncology, gynecology, respiratory diseases, and gastroenterology. Services to be provided include project management, field monitoring, data management, statistics, medical writing,
Onconase, a first-in-class product candidate from Alfacell’s proprietary ribonuclease (RNase) technology has been shown in the laboratory and clinic to target cancer cells while sparing normal cells. Onconase,
With this agreement, Celsion will begin immediate implementation of the study which has been planned in detail during the course of FDA’s review. The study is designed to
The strategic alliance agreement is for five years between Azopharma and Accu-Break Pharmaceuticals (ABP). Azopharma will provide sales and marketing support for Accu-Break technologies for five years. The
The company has also granted the underwriters a 30-day option to purchase up to an additional 1.5 million shares of common stock to cover over-allotments, if any. All
A submission has already been sent to the Swedish Medicinal Products Agency. Additional submissions will be sent to other European countries. The study is proposed to include approximately
Upon completion of the acquisition, Eyeonics’s operations will become part of Bausch & Lomb’s surgical business, which offers a complete line of standard intraocular lenses, phacoemulsification equipment, vitreoretinal
The two medicines in this single-tablet combination work together to lower blood pressure, with clinical data showing that the combination of Tekturna and hydrochlorothiazide (HCTZ) offers greater blood